Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049076666> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2049076666 endingPage "37" @default.
- W2049076666 startingPage "33" @default.
- W2049076666 abstract "Abciximab (c7e3; ReoPro; Centocor, Inc., Pennsylvania, USA), a Fab fragment of the chimeric human-murine monoclonal antibody directed against platelet glycoprotein IIb/IIIa receptors, has been shown to reduce acute ischemic complications in patients undergoing percutaneous coronary interventions (PCI). However, its use has been associated with an increased incidence of bleeding events. The aim of this study is to examine the frequency of bleeding complications and to identify clinical variables associated with it in our patients. We prospectively recorded incidence of bleeding complications in 344 consecutive patients who underwent PCI with adjunctive use of abciximab (Ab). Clinical predictors for patients who developed bleeding complications with Ab were compared with the nonbleeders. Major bleeding occurred in six patients (1.7%) one of whom had pulmonary hemorrhage and one had intracranial hemorrhage. Minor bleeding occurred in 20 (5.8%) patients. Thrombocytopenia was seen in 13 (3.9%) patients of which four (1.2%) were mild, four (1.2%) were severe, and five (1.5%) were profound. Multivariate analyses showed that female gender and the bail-out use of Ab were risk factors for bleeding complications. The rate of major bleeding complications and thrombocytopenia were low and comparable with published trials. Female patients and those who received Ab as a bail-out were at higher risk of developing bleeding complications." @default.
- W2049076666 created "2016-06-24" @default.
- W2049076666 creator A5017356376 @default.
- W2049076666 creator A5033649095 @default.
- W2049076666 creator A5037855177 @default.
- W2049076666 creator A5079110502 @default.
- W2049076666 date "2005-02-01" @default.
- W2049076666 modified "2023-10-16" @default.
- W2049076666 title "Predictors of Bleeding Complications and Thrombocytopenia with the Use of Abciximab during Percutaneous Coronary Intervention" @default.
- W2049076666 cites W2026202162 @default.
- W2049076666 cites W2033767918 @default.
- W2049076666 cites W2050628304 @default.
- W2049076666 cites W2052899600 @default.
- W2049076666 cites W2057744668 @default.
- W2049076666 cites W2078253165 @default.
- W2049076666 cites W2087305090 @default.
- W2049076666 cites W2118895431 @default.
- W2049076666 cites W2121964226 @default.
- W2049076666 cites W2125354973 @default.
- W2049076666 cites W2230838014 @default.
- W2049076666 cites W2281862598 @default.
- W2049076666 cites W2313726388 @default.
- W2049076666 cites W2395313915 @default.
- W2049076666 cites W3022148767 @default.
- W2049076666 cites W4244807166 @default.
- W2049076666 cites W4254730674 @default.
- W2049076666 cites W4256202725 @default.
- W2049076666 doi "https://doi.org/10.1111/j.1540-8183.2005.04031.x" @default.
- W2049076666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15788052" @default.
- W2049076666 hasPublicationYear "2005" @default.
- W2049076666 type Work @default.
- W2049076666 sameAs 2049076666 @default.
- W2049076666 citedByCount "15" @default.
- W2049076666 countsByYear W20490766662013 @default.
- W2049076666 countsByYear W20490766662015 @default.
- W2049076666 countsByYear W20490766662016 @default.
- W2049076666 countsByYear W20490766662017 @default.
- W2049076666 crossrefType "journal-article" @default.
- W2049076666 hasAuthorship W2049076666A5017356376 @default.
- W2049076666 hasAuthorship W2049076666A5033649095 @default.
- W2049076666 hasAuthorship W2049076666A5037855177 @default.
- W2049076666 hasAuthorship W2049076666A5079110502 @default.
- W2049076666 hasConcept C120665830 @default.
- W2049076666 hasConcept C121332964 @default.
- W2049076666 hasConcept C126322002 @default.
- W2049076666 hasConcept C141071460 @default.
- W2049076666 hasConcept C2777871224 @default.
- W2049076666 hasConcept C2780400711 @default.
- W2049076666 hasConcept C45393284 @default.
- W2049076666 hasConcept C500558357 @default.
- W2049076666 hasConcept C61511704 @default.
- W2049076666 hasConcept C71924100 @default.
- W2049076666 hasConcept C81182388 @default.
- W2049076666 hasConceptScore W2049076666C120665830 @default.
- W2049076666 hasConceptScore W2049076666C121332964 @default.
- W2049076666 hasConceptScore W2049076666C126322002 @default.
- W2049076666 hasConceptScore W2049076666C141071460 @default.
- W2049076666 hasConceptScore W2049076666C2777871224 @default.
- W2049076666 hasConceptScore W2049076666C2780400711 @default.
- W2049076666 hasConceptScore W2049076666C45393284 @default.
- W2049076666 hasConceptScore W2049076666C500558357 @default.
- W2049076666 hasConceptScore W2049076666C61511704 @default.
- W2049076666 hasConceptScore W2049076666C71924100 @default.
- W2049076666 hasConceptScore W2049076666C81182388 @default.
- W2049076666 hasIssue "1" @default.
- W2049076666 hasLocation W20490766661 @default.
- W2049076666 hasLocation W20490766662 @default.
- W2049076666 hasOpenAccess W2049076666 @default.
- W2049076666 hasPrimaryLocation W20490766661 @default.
- W2049076666 hasRelatedWork W1972754873 @default.
- W2049076666 hasRelatedWork W1977234073 @default.
- W2049076666 hasRelatedWork W2009292691 @default.
- W2049076666 hasRelatedWork W2033917148 @default.
- W2049076666 hasRelatedWork W2079494746 @default.
- W2049076666 hasRelatedWork W2761804449 @default.
- W2049076666 hasRelatedWork W2762524193 @default.
- W2049076666 hasRelatedWork W2905317511 @default.
- W2049076666 hasRelatedWork W4239474048 @default.
- W2049076666 hasRelatedWork W4240108578 @default.
- W2049076666 hasVolume "18" @default.
- W2049076666 isParatext "false" @default.
- W2049076666 isRetracted "false" @default.
- W2049076666 magId "2049076666" @default.
- W2049076666 workType "article" @default.